platinum has been researched along with Neointima in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, K; Fujimoto, Y; Himi, T; Ishikawa, K; Kadohira, T; Kitahara, H; Kobayashi, Y; Oka, N; Sano, K; Takahara, M | 1 |
| Airaksinen, JK; Karjalainen, PP; Kiviniemi, TO; Mikkelsson, J; Nammas, W; Perälä, A; Pietilä, M; Romppanen, H; Sia, J; Tuomainen, P; Varho, V | 1 |
1 trial(s) available for platinum and Neointima
| Article | Year |
|---|---|
Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Chromium; Coated Materials, Biocompatible; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Finland; Fractional Flow Reserve, Myocardial; Humans; Hyperplasia; Male; Microcirculation; Middle Aged; Neointima; Nitric Oxide; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Single-Blind Method; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome; Vascular Resistance; Vasodilator Agents; Wound Healing | 2016 |
1 other study(ies) available for platinum and Neointima
| Article | Year |
|---|---|
Assessment of strut coverage of everolimus-eluting platinum chromium stent 2 weeks after implantation by optical coherence tomography.
Topics: Absorbable Implants; Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Japan; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Platinum; Polyesters; Prospective Studies; Prosthesis Design; Tomography, Optical Coherence | 2019 |